Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
At Metagenomi, we are creating potentially curative therapeutics using our metagenomics-powered genome editing toolbox.We believe tools with capabilities that go beyond the current technology landscape will be required in order to reach the full therapeutic potential of genome editing. By harnessing the power of metagenomics, the study of genomes recovered from uncultivated organisms in the natural environment, we are discovering and developing asuite of novel genome editing tools with the potential to make any desired therapeutic gene edit, anywhere in the human genome.
| Last: | $1.62 |
|---|---|
| Change Percent: | 2.01% |
| Open: | $1.6 |
| Close: | $1.5881 |
| High: | $1.695 |
| Low: | $1.523 |
| Volume: | 221,572 |
| Last Trade Date Time: | 03/05/2026 12:44:22 pm |
| Market Cap: | $58,948,399 |
|---|---|
| Float: | 30,863,429 |
| Insiders Ownership: | 9% |
| Institutions: | 9 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.metagenomi.co |
| Country: | US |
| City: | Emeryville |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Metagenomi Inc. (NASDAQ: MGX).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.